HOB Biotech Group Corp.,Ltd
688656
Rank in Stocks
#8842
HOB Biotech Group Corp.,Ltd. is an international in vitro diagnostics firm,... HOB Biotech Group Corp.,Ltd. is an international in vitro diagnostics firm, active in both China and various global markets. It supplies advanced diagnostic assays, such as line immune, enzyme-linked immunosorbent, and chemiluminescent paramagnetic microparticle immunoassays, to laboratories and hospitals. This endeavor aims to improve the treatment and care for patients afflicted with allergies and autoimmune diseases. The company was established in 2009 and is headquartered in Suzhou, China.
Share Price
$15.32
Last synced: 2026-11-10
Market Cap
$961.14M
Change (1 day)
-0.89%
Change (1 year)
-39.26%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade HOB Biotech Group Corp.,Ltd (688656)
Category
Healthcare
Operating Margin for HOB Biotech Group Corp.,Ltd (688656)
Operating Margin as of November 2026 TTM: 7.90%
According to HOB Biotech Group Corp.,Ltd's latest financial reports, its current operating margin (TTM) is 7.90%. At the end of 2025 the company had an operating margin of 6.73%.
Operating Margin history for HOB Biotech Group Corp.,Ltd from 2016 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 7.90% | 17.38% |
| 2025 | 6.73% | -34.60% |
| 2024 | 10.29% | -27.33% |
| 2023 | 14.16% | -4.65% |
| 2022 | 14.85% | -51.63% |
| 2021 | 30.70% | 4.64% |
| 2020 | 29.34% | 8.55% |
| 2019 | 27.03% | 10.73% |
| 2018 | 24.41% | 45.30% |
| 2017 | 16.80% | 495.74% |
| 2016 | 2.82% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -98.07% |
US
|
|
| 18.08% | -97.71% |
IE
|
|
| 21.25% | -97.31% |
US
|
|
| 21.05% | -97.34% |
US
|
|
| 28.09% | -96.44% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about HOB Biotech Group Corp.,Ltd's operating margin
What is HOB Biotech Group Corp.,Ltd's operating margin?
HOB Biotech Group Corp.,Ltd's operating margin is 7.90%, as of Nov 2026.
What was HOB Biotech Group Corp.,Ltd's operating margin in 2025?
In 2025, HOB Biotech Group Corp.,Ltd's operating margin was 6.73%, compared with 10.29% in 2024.
How has HOB Biotech Group Corp.,Ltd's operating margin changed since 2020?
From 2020 to 2025, HOB Biotech Group Corp.,Ltd's operating margin was highest in 2021 (30.70%) and lowest in 2025 (6.73%).
How does HOB Biotech Group Corp.,Ltd's operating margin compare with similar companies?
HOB Biotech Group Corp.,Ltd's operating margin (7.90%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.